10x Genomics

TXG

Market cap $2.38B

Buy

Hold

Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$16.8

11% downside

High target

positive

3 neutral

60%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Piper Sandler David Westenberg				11 Nov ‘25 19 days ago
Canaccord Genuity Kyle Mikson 67% 1-yr TXG win rate				7 Nov ‘25 23 days ago
JP Morgan Casey Woodring				7 Nov ‘25 23 days ago
UBS Dan Leonard				7 Nov ‘25 23 days ago
Barclays Luke Sergott 67% 1-yr TXG win rate				7 Nov ‘25 23 days ago